PFE Nov 2024 22.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:16PM EDT. Market open.
| Previous Close | 7.85 |
| Open | 8.05 |
| Bid | 6.55 |
| Ask | 8.85 |
| Strike | 22.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 7.85 - 8.05 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 21 |
ZacksNovartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%
NVS' breast cancer drug Kisqali reduces the risk of disease recurrence by 28.5% in a broad population of patients suffering from early breast cancer.
Business WirePfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
NEW YORK, September 17, 2024--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, October 29, 2024. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2024 Performance Report, to be issued that morning.
ZacksLilly Gets FDA Approval for Eczema Drug Ebglyss
The FDA approves Lilly's Ebglyss based on data from ADvocate 1, ADvocate 2 and ADhere studies.
© 2024 Yahoo. All rights reserved.